Suppr超能文献

以复发性冠状动脉血栓形成为表现的抗磷脂综合征:一例报告。

Antiphospholipid syndrome presenting as recurrent coronary thrombosis: A case report.

作者信息

Liu Xue-Chen, Wang Wei, Wang Lian-Yi

机构信息

First Hospital of Tsinghua University, School of Clinical Medicine, Tsinghua University, Beijing 100016, China.

Heart Center, First Hospital of Tsinghua University, Beijing 100016, China.

出版信息

World J Cardiol. 2024 Aug 26;16(8):491-495. doi: 10.4330/wjc.v16.i8.491.

Abstract

BACKGROUND

Antiphospholipid syndrome (APS) is a chronic autoimmune disease characterized by venous or arterial thrombosis, pregnancy morbidity and a variety of other autoimmune and inflammatory complications. Here, we report a case of APS associated with multiple coronary thromboses.

CASE SUMMARY

The patient, a 28-year-old male, suffered from recurrent coronary thromboses over a period of 31 months. Despite undergoing interventional coronary procedures, thrombolytic therapy, and anticoagulation treatment, the condition persisted intermittently. An extensive search for underlying thrombogenic factors revealed a diagnosis of APS. Accurate adjustment of the medication regimen led to the absence of further acute coronary syndrome (ACS) episodes during the subsequent 20-month follow-up. Although the patient occasionally experiences chest tightness, no further symptoms of distress have been reported.

CONCLUSION

APS can manifest as ACS. Screening for rheumatologic and immunological conditions is essential when encountering patients with multiple coronary thromboses. Treatment strategy should include symptomatic relief and a targeted and aggressive approach to address the underlying pathophysiology.

摘要

背景

抗磷脂综合征(APS)是一种慢性自身免疫性疾病,其特征为静脉或动脉血栓形成、妊娠并发症以及多种其他自身免疫和炎症并发症。在此,我们报告一例与多发性冠状动脉血栓形成相关的抗磷脂综合征病例。

病例摘要

该患者为一名28岁男性,在31个月的时间里反复发生冠状动脉血栓形成。尽管接受了冠状动脉介入手术、溶栓治疗和抗凝治疗,但病情仍间歇性持续。对潜在血栓形成因素进行广泛排查后确诊为抗磷脂综合征。准确调整药物治疗方案后,在随后20个月的随访期间未再出现急性冠状动脉综合征(ACS)发作。尽管患者偶尔仍会感到胸闷,但未报告进一步的不适症状。

结论

抗磷脂综合征可表现为急性冠状动脉综合征。遇到多发性冠状动脉血栓形成的患者时,筛查风湿和免疫状况至关重要。治疗策略应包括缓解症状以及针对潜在病理生理机制采取有针对性的积极措施。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4092/11362805/c83f8eed98e8/WJC-16-491-g001.jpg

相似文献

1
Antiphospholipid syndrome presenting as recurrent coronary thrombosis: A case report.
World J Cardiol. 2024 Aug 26;16(8):491-495. doi: 10.4330/wjc.v16.i8.491.
4
Thrombosis and APS: Lessons Learned from Another Black Swan Tale.
Lupus. 2023 Dec;32(14):1681-1685. doi: 10.1177/09612033231212088. Epub 2023 Nov 2.
5
The antiphospholipid syndrome: from pathophysiology to treatment.
Clin Exp Med. 2017 Aug;17(3):257-267. doi: 10.1007/s10238-016-0430-5. Epub 2016 Jun 22.
6
Antiphospholipid syndrome - an update.
Vasa. 2018 Oct;47(6):451-464. doi: 10.1024/0301-1526/a000723. Epub 2018 Sep 12.
7
9
Acute thrombosis after elective direct intracoronary stenting in primary antiphospholipid syndrome: a case report.
Kaohsiung J Med Sci. 2003 Apr;19(4):177-82. doi: 10.1016/S1607-551X(09)70468-1.
10
Intravenous immunoglobulins and antiphospholipid syndrome: How, when and why? A review of the literature.
Autoimmun Rev. 2016 Mar;15(3):226-35. doi: 10.1016/j.autrev.2015.11.009. Epub 2015 Dec 1.

本文引用的文献

1
Rethinking antiphospholipid syndrome to guide future management and research.
Nat Rev Rheumatol. 2024 Jun;20(6):377-388. doi: 10.1038/s41584-024-01110-y. Epub 2024 May 3.
2
Antiphospholipid syndrome: advances in diagnosis, pathogenesis, and management.
BMJ. 2023 Feb 27;380:e069717. doi: 10.1136/bmj-2021-069717.
3
Management of Acute Coronary Syndrome.
Emerg Med Clin North Am. 2022 Nov;40(4):693-706. doi: 10.1016/j.emc.2022.06.008.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验